217 Publications (Page 1 of 9)
2021
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence
Nguyen, Ryan HNguyen, Ryan HVater, Laura BVater, Laura BTimsina, Lava RTimsina, Lava RDurm, Gregory ADurm, Gregory ARupp, KatelinRupp, KatelinWright, KeyleeWright, KeyleeSpitznagle, Miranda HSpitznagle, Miranda HBrandy, PaulBrandy, PaulJalal, Shadia IJalal, Shadia ICarter-Harris, LisaCarter-Harris, LisaHudmon, Karen SHudmon, Karen SHanna, Nasser HHanna, Nasser HLoehrer, Patrick JLoehrer, Patrick JCeppa, DuyKhanh P and Ceppa, DuyKhanh P
PLoS One, vol. 16, (no. 4), Apr 2021. | Journal Article
 
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
Ashkar, RyanAshkar, RyanAshkar, RyanAshkar, RyanFeldman, Darren RFeldman, Darren RFeldman, Darren RFeldman, Darren RAdra, NabilAdra, NabilZaid, Mohammad AbuZaid, Mohammad AZaid, Mohammad AbuZaid, Mohammad AFunt, Samuel AFunt, Samuel AFunt, Samuel AFunt, Samuel AAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KPerkins, Susan MPerkins, Susan MPerkins, Susan MPerkins, Susan MSnow, Christin ISnow, Christin ISnow, Christin ISnow, Christin ILazzara, Kayla MLazzara, Kayla MLazzara, Kayla MLazzara, Kayla MSego, Lina MSego, Lina MSego, Lina MSego, Lina MQuinn, David IQuinn, David IQuinn, David IQuinn, David IHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineCostantine, AlbanyAlbany, Costantine and Costantine, Albany
Investigational New Drugs, vol. 39, (no. 6), pp. 1656-1663, Dec 2021. | Journal Article
2020
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179
Durm, Greg ADurm, Greg ADurm, Greg ADurm, Greg ADurm, Greg AJabbour, Salma KJabbour, Salma KJabbour, Salma KJabbour, Salma KJabbour, Salma KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KLiu, ZiyueLiu, ZiyueLiu, ZiyueLiu, ZiyueLiu, ZiyueSadiq, Ahad ASadiq, Ahad ASadiq, Ahad ASadiq, Ahad ASadiq, Ahad AZon, Robin TZon, Robin TZon, Robin TZon, Robin TZon, Robin TJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IKloecker, Goetz HKloecker, Goetz HKloecker, Goetz HKloecker, Goetz HKloecker, Goetz HWilliamson, Michael JWilliamson, Michael JWilliamson, Michael JWilliamson, Michael JWilliamson, Michael JReckamp, Karen LReckamp, Karen LReckamp, Karen LReckamp, Karen LReckamp, Karen LLangdon, Robert MLangdon, Robert MLangdon, Robert MLangdon, Robert MLangdon, Robert MKio, Ebenezer AKio, Ebenezer AKio, Ebenezer AKio, Ebenezer AKio, Ebenezer AGentzler, Ryan DGentzler, Ryan DGentzler, Ryan DGentzler, Ryan DGentzler, Ryan DAdesunloye, Bamidele AAdesunloye, Bamidele AAdesunloye, Bamidele AAdesunloye, Bamidele AAdesunloye, Bamidele AHarb, Wael AHarb, Wael AHarb, Wael AHarb, Wael AHarb, Wael AWalling, Radhika VWalling, Radhika VWalling, Radhika VWalling, Radhika VWalling, Radhika VTitzer, Michael LTitzer, Michael LTitzer, Michael LTitzer, Michael LTitzer, Michael LHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser H and Hanna, Nasser H
Cancer, vol. 126, (no. 19), pp. 4353-4361, Oct 2020. | Journal Article
 
A phase II study assessing the safety and efficacy of ASP1650 in male patients with incurable platinum refractory germ cell tumors
Adra, NabilAdra, NabilAdra, NabilVaughn, David JVaughn, David JVaughn, David JEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceHanna, Nasser HHanna, Nasser HHanna, Nasser HRosales, MattRosales, MattRosales, MattArozullah, AhsanArozullah, AhsanArozullah, AhsanFeldman, Darren RFeldman, Darren R and Feldman, Darren R
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. TPS424, 2020-02-20. | Journal Article
 
A phase I study of guadecitabine (SGI-110) plus cisplatin in patients with platinum refractory germ cell tumors
Albany, CostantineAlbany, CostantineAlbany, CostantineSpinella, Michael JSpinella, Michael JSpinella, Michael JAdra, NabilAdra, NabilAdra, NabilHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, LawrenceEinhorn, Lawrence and Einhorn, Lawrence
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 408, 2020-02-20. | Journal Article
 
Computer-Tailored Decision Support Tool for Lung Cancer Screening: Community-Based Pilot Randomized Controlled Trial
Carter-Harris, LisaComer, Robert SSlaven, James EMonahan, Patrick OVode, EmileeHanna, Nasser HCeppa, DuyKhanh P and Rawl, Susan M
Journal of Medical Internet Research, vol. 22, (no. 11), Nov 2020. | Journal Article
 
High‐dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases
Kalra, MaitriKalra, MaitriKalra, MaitriKalra, MaitriAdra, NabilAdra, NabilAdra, NabilAdra, NabilHanna, NasserHanna, NasserHanna, NasserHanna, NasserAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Cancer, vol. 126, (no. 6), pp. 1202-1207, Mar 2020. | Journal Article
 
Lung Cancer Screening Knowledge Among Internal Medicine Residents in a University Program
Urrutia Argueta, Samuel and Hanna, Nasser
Journal of cancer education : the official journal of the American Association for Cancer Education, 2020-Apr-19. | Journal Article
 
Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
Shukla, Nikhil A and Hanna, Nasser H
Lung Cancer Management, vol. 9, (no. 1), pp. LMT23, 20200201. | Journal Article
 
Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)
Adra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceEinhorn, Lawrence and Einhorn, Lawrence
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 403, 2020-02-20. | Journal Article
 
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Taza, FadiTaza, FadiTaza, FadiTaza, FadiTaza, FadiTaza, FadiChovanec, MichalChovanec, MichalChovanec, MichalChovanec, MichalChovanec, MichalChovanec, MichalSnavely, AnnaSnavely, AnnaSnavely, AnnaSnavely, AnnaSnavely, AnnaSnavely, AnnaHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, Richard SFoster, Richard SFoster, Richard SFoster, Richard SFoster, Richard SFoster, Richard SEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, Nabil and Adra, Nabil
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 12), pp. 1345, 2020-Apr-20. | Journal Article
 
Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179
Anouti, BilalAnouti, BilalAlthouse, SandraAlthouse, SandraDurm, GregDurm, GregHanna, Nasser and Hanna, Nasser
Clinical Lung Cancer, vol. 21, (no. 3), pp. 293, May 2020. | Journal Article
 
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Phase I Study Protocol
McClelland, ShearwoodMcClelland, ShearwoodMc Clelland, ShearwoodMcClelland, ShearwoodMcClelland, ShearwoodMcClelland, ShearwoodLautenschlaeger, TimLautenschlaeger, TimLautenschlaeger, TimLautenschlaeger, TimLautenschlaeger, TimLautenschlaeger, TimZang, YongZang, YongZang, YongZang, YongZang, YongZang, YongHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HShiue, KevinShiue, KevinShiue, KevinShiue, KevinShiue, KevinShiue, KevinKamer, Aaron PKamer, Aaron PKamer, Aaron PKamer, Aaron PKamer, Aaron PKamer, Aaron PAgrawal, NamitaAgrawal, NamitaAgrawal, NamitaAgrawal, NamitaAgrawal, NamitaAgrawal, NamitaEllsworth, Susannah GEllsworth, Susannah GEllsworth, Susannah GEllsworth, Susannah GEllsworth, Susannah GEllsworth, Susannah GRhome, Ryan MRhome, Ryan MRhome, Ryan MRhome, Ryan MRhome, Ryan MRhome, Ryan MWatson, Gordon AWatson, Gordon AWatson, Gordon AWatson, Gordon AWatson, Gordon A and Watson, Gordon A
Reports of Practical Oncology & Radiotherapy, 2020-04-00. | Journal Article
 
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors
Zhang, Kevin JuanZhang, Kevin JuanZhang, Kevin JuanZhang, Kevin JuanZhang, Kevin JuanHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAdra, NabilAdra, NabilAdra, NabilAdra, Nabil and Adra, Nabil
Clinical Genitourinary Cancer, 2020-Feb-08. | Journal Article
 
The Case for Maintenance Pemetrexed Plus Bevacizumab
Hanna, NasserHanna, NasserJalal, Shadia and Jalal, Shadia
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 7), pp. 771, 2020-Mar-01. | Journal Article
 
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Hanna, Nasser HHanna, Nasser HSchneider, Bryan JSchneider, Bryan JTemin, SarahTemin, SarahBaker, Jr, ShermanBaker, Jr, ShermanBrahmer, JulieBrahmer, JulieEllis, Peter MEllis, Peter MGaspar, Laurie EGaspar, Laurie EHaddad, Rami YHaddad, Rami YHesketh, Paul JHesketh, Paul JJain, DharamvirJain, DharamvirJaiyesimi, IshmaelJaiyesimi, IshmaelJohnson, David HJohnson, David HLeighl, Natasha BLeighl, Natasha BPhillips, TanyanikaPhillips, TanyanikaRiely, Gregory JRiely, Gregory JRobinson, Andrew GRobinson, Andrew GRosell, RafaelRosell, RafaelSchiller, Joan HSchiller, Joan HSingh, NavneetSingh, NavneetSpigel, David RSpigel, David RStabler, Janis OStabler, Janis OTashbar, JoanTashbar, JoanMasters, Gregory and Masters, Gregory
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 14), pp. 1632, 2020-May-10. | Journal Article
 
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary
Hanna, Nasser HTemin, Sarah and Masters, Gregory
JCO oncology practice, pp. JOP1900770, 2020-Feb-24. | Journal Article
 
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary
Hanna, Nasser HTemin, Sarah and Masters, Gregory
JCO Oncology Practice, pp. JOP1900770, 2020-02-24. | Journal Article
 
The Story of Angiogenesis Inhibitors in Non–small-cell Lung Cancer: The Past, Present, and Future
Shukla, Nikhil AtulYan, Melissa Noela and Hanna, Nasser
Clinical Lung Cancer, 2020-Mar-12. | Journal Article
2019
Acceptance and Commitment Therapy for Symptom Interference in Advanced Lung Cancer and Caregiver Distress: A Pilot Randomized Trial
Mosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine EMosher, Catherine ESecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinSecinti, EkinHirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THirsh, Adam THanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserHanna, NasserEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IJalal, Shadia IDurm, GregoryDurm, GregoryDurm, GregoryDurm, GregoryDurm, GregoryDurm, GregoryDurm, GregoryDurm, GregoryChampion, Victoria LChampion, Victoria LChampion, Victoria LChampion, Victoria LChampion, Victoria LChampion, Victoria LChampion, Victoria LChampion, Victoria LJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, Shelley AJohns, Shelley A and Johns, Shelley A
Journal of Pain and Symptom Management, vol. 58, (no. 4), Oct 2019. | Journal Article
 
Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy
Albany, CostantineAlbany, CostantineDockter, TravisDockter, TravisWolfe, Eric GWolfe, Eric GPachman, Deirdre RPachman, Deirdre RWagner-Johnston, Nina DWagner-Johnston, Nina DLazzara, Kayla MarieLazzara, Kayla MarieSego, Lina MSego, Lina MEdwards, Sara IEdwards, Sara ISnow, Christin ISnow, Christin IHanna, NasserHanna, NasserEinhorn, LawrenceEinhorn, LawrenceLoprinzi, Charles LLoprinzi, Charles LCostello, Brian Addis and Costello, Brian Addis
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e23078, 2019-05-20. | Journal Article
 
Crowdfunding for lung cancer costs
Nguyen, RyanHanna, Nasser H and Vater, Laura
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e18340, 2019-05-20. | Journal Article
 
Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence
Nguyen, RyanNguyen, RyanNguyen, RyanNguyen, RyanNguyen, RyanNguyen, RyanNguyen, RyanVater, LauraVater, LauraVater, LauraVater, LauraVater, LauraVater, LauraVater, LauraTimsina, Lava RTimsina, Lava RTimsina, Lava RTimsina, Lava RTimsina, Lava RTimsina, Lava RTimsina, Lava RDurm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewDurm, Greg AndrewRupp, KatelinRupp, KatelinRupp, KatelinRupp, KatelinRupp, KatelinRupp, KatelinRupp, KatelinWright, KeyleeWright, KeyleeWright, KeyleeWright, KeyleeWright, KeyleeWright, KeyleeWright, KeyleeSpitznagle, MirandaSpitznagle, MirandaSpitznagle, MirandaSpitznagle, MirandaSpitznagle, MirandaSpitznagle, MirandaSpitznagle, MirandaPaul, BrandyPaul, BrandyPaul, BrandyPaul, BrandyPaul, BrandyPaul, BrandyPaul, BrandyJalal, Shadia IbrahimJalal, Shadia IbrahimJalal, Shadia IbrahimJalal, Shadia IbrahimJalal, Shadia IbrahimJalal, Shadia IbrahimJalal, Shadia IbrahimCarter-Harris, LisaCarter-Harris, LisaCarter-Harris, LisaCarter-Harris, LisaCarter-Harris, LisaCarter-Harris, LisaCarter-Harris, LisaHudmon, Karen SHudmon, Karen SHudmon, Karen SHudmon, Karen SHudmon, Karen SHudmon, Karen SHudmon, Karen SHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JLoehrer, Patrick JCeppa, DuyKhanhCeppa, DuyKhanhCeppa, DuyKhanhCeppa, DuyKhanhCeppa, DuyKhanhCeppa, DuyKhanh and Ceppa, DuyKhanh
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 6578, 2019-05-20. | Journal Article
 
Interim safety analysis of consolidation nivolumab and ipilimumab versus nivolumab alone following concurrent chemoradiation for unresectable stage IIIA/IIIB NSCLC: Big Ten Cancer Research Consortium LUN 16-081
Yan, MelissaYan, MelissaDurm, Greg AndrewDurm, Greg AndrewMamdani, HirvaMamdani, HirvaGanti, Apar KishorGanti, Apar KishorHrinczenko, BorysHrinczenko, BorysJabbour, Salma KJabbour, Salma KFeldman, Lawrence EricFeldman, Lawrence EricKloecker, Goetz HKloecker, Goetz HLeal, TicianaLeal, TicianaAlmokadem, SalahAlmokadem, SalahNaidoo, JarushkaNaidoo, JarushkaFujioka, NaomiFujioka, NaomiHanna, Nasser H and Hanna, Nasser H
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 8535, 2019-05-20. | Journal Article
 
Predicting progression of in situ carcinoma in the era of precision genomics
Cheng, MonicaCheng, MonicaCheng, MonicaCheng, MonicaHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DDavidson, Darrell DGunderman, Richard BGunderman, Richard BGunderman, Richard B and Gunderman, Richard B
Journal of thoracic disease, vol. 11, (no. 6), pp. 2225, 2019-Jun. | Journal Article